BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26235890)

  • 1. Role of linoleic acid in arsenical palmar keratosis.
    Ahmed TS; Misbahuddin M
    Int J Dermatol; 2016 Mar; 55(3):289-95. PubMed ID: 26235890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic groundwater contamination and its health effects in Patna district (capital of Bihar) in the middle Ganga plain, India.
    Chakraborti D; Rahman MM; Ahamed S; Dutta RN; Pati S; Mukherjee SC
    Chemosphere; 2016 Jun; 152():520-9. PubMed ID: 27011321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic Keratosis in a Patient from Newfoundland and Labrador, Canada: Case Report and Review.
    Pratt M; Wadden P; Gulliver W
    J Cutan Med Surg; 2016 Jan; 20(1):67-71. PubMed ID: 26239734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling reveals candidate markers for arsenic-induced skin keratosis.
    Guo Z; Hu Q; Tian J; Yan L; Jing C; Xie HQ; Bao W; Rice RH; Zhao B; Jiang G
    Environ Pollut; 2016 Nov; 218():34-38. PubMed ID: 27552035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papular palmoplantar hyperkeratosis following chronic medical exposure to arsenic: human papillomavirus as a co-factor in the pathogenesis of arsenical keratosis?
    Gerdsen R; Stockfleth E; Uerlich M; Fartasch M; Steen KH; Bieber T
    Acta Derm Venereol; 2000; 80(4):292-3. PubMed ID: 11028865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmoplantar keratosis caused by arsenic toxicity.
    Patel K; Gin A; Scardamaglia L
    Med J Aust; 2021 Apr; 214(6):258. PubMed ID: 33629396
    [No Abstract]   [Full Text] [Related]  

  • 7. Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia.
    Guo X; Liu Z; Huang C; You L
    J Health Popul Nutr; 2006 Jun; 24(2):214-20. PubMed ID: 17195562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-trace elements level in drinking water and the prevalence of multi-chronic arsenical poisoning in residents in the west area of Iran.
    Barati AH; Maleki A; Alasvand M
    Sci Total Environ; 2010 Mar; 408(7):1523-9. PubMed ID: 20092875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective beta1-integrins expression in arsenical keratosis and arsenic-treated cultured human keratinocytes.
    Lee CH; Chen JS; Sun YL; Liao WT; Zheng YW; Chai CZ; Chen GS; Yu HS
    J Cutan Pathol; 2006 Feb; 33(2):129-38. PubMed ID: 16420308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of spirulina extract plus zinc in patients of chronic arsenic poisoning: a randomized placebo-controlled study.
    Misbahuddin M; Islam AZ; Khandker S; Ifthaker-Al-Mahmud ; Islam N; Anjumanara
    Clin Toxicol (Phila); 2006; 44(2):135-41. PubMed ID: 16615668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of palmoplantar arsenical keratosis with a combination of keratolytics and low-dose acitretin.
    Son SB; Song HJ; Son SW
    Clin Exp Dermatol; 2008 Mar; 33(2):202-4. PubMed ID: 18039342
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of dietary arsenic exposure and its biomarkers: a case study of West Bengal, India.
    Mazumder DN; Deb D; Biswas A; Saha C; Nandy A; Ganguly B; Ghose A; Bhattacharya K; Majumdar KK
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(8):896-904. PubMed ID: 23485239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic arsenic toxicity from Ayurvedic medicines.
    Khandpur S; Malhotra AK; Bhatia V; Gupta S; Sharma VK; Mishra R; Arora NK
    Int J Dermatol; 2008 Jun; 47(6):618-21. PubMed ID: 18477160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous manifestations of occupational chronic arsenical poisoning. (Studies on lead arsenate poisoning, Part 3).
    Hamada T; Horiguchi S; Nakano H
    Osaka City Med J; 1977; 23(1):9-20. PubMed ID: 147434
    [No Abstract]   [Full Text] [Related]  

  • 15. Palmoplantar keratosis and raindrop pigmentation in chronic arsenicosis.
    Sil A; Bhanja DB; Panigrahi A; Mondal S; Datta M
    QJM; 2020 Aug; 113(8):584-585. PubMed ID: 31769841
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of clinical complications with nutritional status and the prevalence of leukopenia among arsenic patients in Bangladesh.
    Islam LN; Nabi AH; Rahman MM; Khan MA; Kazi AI
    Int J Environ Res Public Health; 2004 Sep; 1(2):74-82. PubMed ID: 16696181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic groundwater contamination and its health effects in the state of Uttar Pradesh (UP) in upper and middle Ganga plain, India: a severe danger.
    Ahamed S; Kumar Sengupta M; Mukherjee A; Amir Hossain M; Das B; Nayak B; Pal A; Chandra Mukherjee S; Pati S; Nath Dutta R; Chatterjee G; Mukherjee A; Srivastava R; Chakraborti D
    Sci Total Environ; 2006 Nov; 370(2-3):310-22. PubMed ID: 16899281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manifestation of arsenicosis patients and factors determining the duration of arsenic symptoms in Bangladesh.
    Hossain MK; Khan MM; Alam MA; Chowdhury AK; Delwar Hossain M; Feroze Ahmed M; Kobayashi K; Sakauchi F; Mori M
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):78-86. PubMed ID: 16164963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
    Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
    Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin manifestations of arsenicosis in two villages in Bangladesh.
    Kadono T; Inaoka T; Murayama N; Ushijima K; Nagano M; Nakamura S; Watanabe C; Tamaki K; Ohtsuka R
    Int J Dermatol; 2002 Dec; 41(12):841-6. PubMed ID: 12492966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.